Dalbavancin in Real Life: Economic Impact of Prescription Timing in French Hospitals
Author:
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical)
Link
https://link.springer.com/content/pdf/10.1007/s40121-021-00577-6.pdf
Reference31 articles.
1. Soriano A, Rossolini GM, Pea F. The role of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs). Expert Rev Antiinfect Ther. 2020;18:415–22.
2. Keyloun KR, Lofgren E, Hebert S. Modeling operational quality metrics and costs of long-acting antibiotics for acute bacterial skin and skin structure infection treatment in the emergency department. J Med Econ. 2019;22:652–61.
3. Morata L, Cobo J, Fernández-Sampedro M, et al. Safety and efficacy of prolonged use of dalbavancin in bone and joint infections. Antimicrob Agents Chemother. 2019;63(5):e02280–18. https://doi.org/10.1128/AAC.02280-18.
4. Tobudic S, Forstner C, Burgmann H, et al. Dalbavancin as primary and sequential treatment for gram-positive infective endocarditis: 2-year experience at the General Hospital of Vienna. Clin Infect Dis. 2018;67:795–8.
5. Hidalgo-Tenorio C, Vinuesa D, Plata A, et al. DALBACEN cohort: dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci. Ann Clin Microbiol Antimicrob. 2019;18:30.
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. What Place Is There for Long-Acting Antibiotics in the Management of Gram-Positive Infections? A Qualitative Cross-Sectional Study;Antibiotics;2024-07-12
2. Dalbavancin as sequential therapy in infective endocarditis: Real-life experience in elder and comorbid patients;Enfermedades infecciosas y microbiologia clinica (English ed.);2024-06
3. Dalbavancin as sequential therapy in infective endocarditis: Real-life experience in elder and comorbid patients;Enfermedades Infecciosas y Microbiología Clínica;2024-06
4. In-label, off-label prescription, efficacy and tolerability of dalbavancin: report from a National Registry;Infection;2024-02-07
5. Comparison of dalbavancin with standard of care in the management of infective endocarditis: efficacy, safety, and cost analysis;International Journal of Infectious Diseases;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3